Products & Services · Share of non-controling interest recognized
LEQEMBI Collaboration — Share of non-controling interest recognized
Analysis
StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ4 2025
How to read this metric
An increase indicates higher earnings allocated to partners, while a decrease suggests a larger portion of the collaboration's financial results is retained by the company.
Detailed definition
This metric represents the portion of net income or loss attributable to non-controlling interests within a specific col...
Peer comparison
Common in pharmaceutical co-development agreements where profit-sharing ratios are defined by contractual terms.
Metric ID:
biib_segment_leqembi_collaboration_share_of_non_controling_interest_recognizedHistorical Data
1 periods
| Q4 '25 | |
|---|---|
| Value | 50% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's leqembi collaboration — share of non-controling interest recognized?
- Biogen (BIIB) reported leqembi collaboration — share of non-controling interest recognized of 50.0% in Q4 2025.
- What does leqembi collaboration — share of non-controling interest recognized mean?
- The share of profits or losses from a joint product collaboration that belongs to external partners rather than the company.